Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.
Durcan R. et al, (2025), BMJ Open, 15
Decoding dynamic brain networks in Parkinson's disease with temporal attention.
Patel SB. et al, (2025), Sci Rep, 15
Pathway to Regulatory Approval of Digital Health Technologies in Progressive Supranuclear Palsy: A Scoping Review.
Isroff C. et al, (2025), Brain Sci, 15
Verbal fluency is associated with Gait impairment in Progressive Supranuclear Palsy
D’Souza A. et al, (2025), Clinical Parkinsonism & Related Disorders, 13, 100380 - 100380
Quantitative Oculomotor and Vestibular Profile in Spinocerebellar Ataxia Type 6 - Systematic Review and Meta-Analysis.
Tarnutzer AA. et al, (2024), Cerebellum, 24
Accelerating Parkinson's Disease drug development with federated learning approaches.
Khanna A. et al, (2024), NPJ Parkinsons Dis, 10
Defining an ageing-related pathology, disease or syndrome: International Consensus Statement.
Short E. et al, (2024), Geroscience
Retinal morphological differences in atypical Parkinsonism: A cross-sectional analysis of the AlzEye cohort
Patel S. et al, (2024), Biomarkers in Neuropsychiatry, 10
Differential effects of bilateral hippocampal CA3 damage on the implicit learning and recognition of complex event sequences.
Miller TD. et al, (2024), Cogn Neurosci, 1 - 29
A novel machine learning based framework for developing composite digital biomarkers of disease progression.
Zhai S. et al, (2024), Front Digit Health, 6
Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools
ANTONIADES C., (2023), Trends in Neurosciences
Using Smartphone Sensors for Ataxia Trials: Consensus Guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers
ANTONIADES C., (2023), The Cerebellum: an international journal from neurosciences to clinical perspectives
Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease.
Wagner SK. et al, (2023), Neurology, 101, e1581 - e1593
Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning
Sotirakis C. et al, (2023), npj Parkinson's Disease, 9
Antiparkinsonian medication masks motor signal progression in de novo patients
Brzezicki MA. et al, (2023), Heliyon, 9, e16415 - e16415